Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents

Journal of Psychiatric Research

Volumn 31, Issue 1, 1997, Pages 133-147

  Rowe, Katherine S ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOLOGIC AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTHRALGIA; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPNEA; FATIGUE; FEVER; FOLLOW UP; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MUSCLE WEAKNESS; MYALGIA; NAUSEA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL; SCHOOL CHILD; SOCIAL BEHAVIOR; VERTIGO; VOMITING;

ADOLESCENT; CHILD; DOUBLE-BLIND METHOD; FATIGUE SYNDROME, CHRONIC; FEMALE; GAMMA-GLOBULINS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PLACEBOS; TREATMENT OUTCOME;

EID: 0031009231     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(96)00047-7     Document Type: Conference Paper

References (38)

1. Achenbach, T. M., & Edelbrock, C. S. (1983). Manual for the Child Behavior Checklist and Revised Child Behavior Profile. Queen City, TX: Queen City Printer Inc.
2. Barker, E., Fujimura, S. F., Fadem, M. B., Landay, A. L., & Levy, J. A. (1994). Immunological abnormalities associated with Chronic Fatigue Syndrome. Clinical Infectious Diseases, 18, S136-141.
3. TM. Scientific Software. Inc. Statistical Design Analysis System..
4. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. K. (1961). An inventory for measuring depression. Arch Gen Psychiatry, 41, 561-571.
5. Behan, P., & Behan, W., Bell, E. (1985). The postviral fatigue syndrome-an analysis of the findings in 50 cases. J Infection, 10, 211-222.
6. Berkman, S. A., Lee, M. L., & Gale, R. P. (1990). Clinical uses of intravenous immunoglobulins. Ann Intern Med, 112, 278-292.
7. Blakely, A. A., Howard, R. C., Sosich, R. M., Murdoch, J. C, Menkes, D. B., & Spears, G. F. S. (1991). Psychiatric symptoms, personality and ways of coping in Chronic Fatigue Syndrome. Psychological Medicine, 21, 347-362.
8. Blanchette V. M., Imbach, P., Andrew, M., Adams, M., McMillan, J., Wang, E., Milner, R., Kaiser, A., Barnard, D., Bernstein, M., Chan, K. W., Esseltine, D., deVeber, B., Israels, S., Kobrinsky, N., & Luke, B. (1994). Randomized trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocyopenic purpura. Lancet, 344, 703-707.
9. Corriel, R. N., Kniker, W. T., McBryde, J. L., & Lesourd, B. M. (1985). Cell mediated immunity in schoolchildren assessed by multitest skin tesing. Normal values and proposed scoring for healthy children. A J D C. 139, 141-146.
10. Dwyer, J. M. (1987). Intravenous therapy with gamma globulin. Adv Intern Med, 32, 111-136
11. Fukuda, K., Straus, S., Hickie, I., Sharpe, M. C., Dobbins, J. G., & Komaroff, A. (1994). The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med, 121, 953-959.
12. Goldberg, D. P., & Williams, P., (1988). A users guide to the general health questionnaire. Windsor: NFER-Nelson.
13. Heiligenstein, E., & Jacobsen, P. B. (1988). Differentiating depression in medically ill children and adolescents. J Am Acad Child Adolesc Psychiatry, 27, 716-719.
14. Holmes, G. P., Kaplan, J. E., Gantz, N. M., Komaroff, A. L., Schonberger, L. B., Straus, S. E., Jones, J. F., Dubois, R. E., Cunningham-Rundles, C., Pahwa, S., Tosato, G., Zegans, L. S., Purtilo, D. T., Brown, N., Schooley, R. T., & Brus, I. (1988). Chronic Fatigue Syndrome: a working case definition. Ann Intern Med., 108(3), 387-389.
15. Imbach, P., d'Appuzzo, V., Hurt, A., Baradun, S., Baumgartner, C., Morell, A., Rossi, E., Schoni, M., Vest, M., & Wagner, H. P. (1981). High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in children. Lancet, I 1228-31.
16. Imbach, P. (Ed.), (1991). Immunotherapy with intravenous immunoglobulins. Proceedings of a conference held at Interlaken May 1990. London: Harcourt Brace Jovanovich.
17. Institut Merieux (1982) Multitest® CMI a skin test for evaluation of cell-mediated immunity. Paris: Institut Merieux.
18. Kniker, W., Anderson, C., McBryde, J., Roumiantzeff, M., Leonard, B. (1984) Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the U.S.A., Ann Allergy, 52, 75-82.
19. Krener, P., & Adelman, R. (1988). Parent salvage and parent sabotage in the care of chronically ill children. AJDC, 142, 945-951.
20. Lloyd, A. (1994). Immunological studies of chronic fatigue syndrome. Introduction. Clinical Infectious Diseases, 18, 5134-135.
21. Lloyd, A., Hickie, I., Hickie, C., Dwyer, J., & Wakefield, D. (1992). Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin. Exp. Immunol., 87(1), 76-79.
22. Lloyd, A., Hickie, I., Wakefield, D., Boughton, C., & Dwyer, J. (1990). A double-blind placebo-controlled trial of intravenous immunoglobulin therapy in patients with the chronic fatigue syndrome. Am J Med, 89, 561-568.
23. Lloyd, A., Wakefield, D., Boughton, C., & Dwyer, J. (1988). What is myalgic encephalomyelitis? Lancet, 1, 1286-1287.
24. Lloyd, A., Wakefield, D., Boughton, C., & Dwyer, J. (1989). Immunological abnormalities in the chronic fatigue syndrome. Med J Aust, 151, 122-124.
25. Murdoch, J. (1988). Cell-mediated immunity in patients with myalgic encephalomyelitis syndrome. New Zealand Med J., 101, 511-512.
26. Peterson, P. K., Shepard, J., & Macres, M. (1990). A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med., 89, 554-560.
27. Rowe, K. S., Fitzgerald, P., Higgins, R., & Anderson, G., Brewin, T. (1993). Educational strategies for chronically ill students with a special section on chronic fatigue syndrome. Set Research papers for teachers., 2.
28. Rowe, K. S., Brewin, T., Fitzgerald, P., & Higgins, R. (1994). The clinical managment of adolescents with chronic fatigue syndrome. Paper presented to the 1st International Conference of the American Chronic Fatigue Syndrome Society, FL, U.S.A., October 1994.
29. Schiavotto, C., Ruggeri, M., & Rodeghiero, F. (1993) Adverse reactions after high-dose intravenous immunoglobulin in 83 patients treated for idiopathic thrombocytopaenic purpura (ITP) and review of the literature. Haematologica (6 suppl 2), 78, 35-40.
30. Spielberger C. D., (1977) Self-evaluation questionnaire state trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press.
31. 12U), in chronic fatigue syndrome. Clinical Infectious Diseases, 18, S88-95.
32. Statistical Package for Social Sciences (1991). SPSS/PC+ version 4·0, Chicago: SPSS Inc.
33. Tirelli, U., Marotta, G., Improta, S., & Pinto, A. (1994). Immunological abnormalities in patients with chronic fatigue syndrome. Scandinavian Journal of Immunology, 40, 601-608.
34. Thase, M. E. (1991). Assessment of depression in patients with chronic fatigue syndrome. Reviews of Infectious Diseases, 13(Suppl 1), 114-118.
35. Wakefield, D., & Lloyd, A. (1987). Pathophysiology of myalgic encephalomyelitis. Lancet, 2, 918-919.
36. Wilson, A., Hickie, I., Lloyd, A., Hadzi-Pavlovic, D., Boughton, C., Dwyer, J., & Wakefield, D. (1994). Longitudinal study of outcome of chronic fatigue syndrome. BMJ, 308, 756-759.
37. Woodward, R. V., Broom, D. H., & Legge, D. G. (1995). Diagnosis in chronic illness: disabling or enabling-the case of chronic fatigue syndrome. J. R. Soc. Med., 88(6), 325-329
38. World Health Organization (1983). Expert Committee on biological standardization. Report of an informal meeting on immunoglobulins (Human) (Geneva, 29 Nov-1 Dec 1982), WHO.